Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer
Cancer Medicine · 2024-02 · 13 (3)
DOI: 10.1002/cam4.7053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2024-03. Verfasst von Alexis K Elfstrum und 2 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Mammary Glands, Human, Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NICHD NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Introduction
Macrophages are innate immune cells that are associated with extensive phenotypic and functional plasticity and contribute to normal development, tissue homeostasis, and diseases such as cancer. In this review, we discuss the heterogeneity of tissue resident macrophages in the normal mammary gland and tumor‐associated macrophages in breast cancer. Tissue resident macrophages are required for mammary gland development, where they have been implicated in promoting extracellular matrix remodeling, apoptotic clearance, and cellular crosstalk. In the context of cancer, tumor‐associated macrophages are key drivers of growth and metastasis via their ability to promote matrix remodeling, angiogenesis, lymphangiogenesis, and immunosuppression.
Method
We identified and summarized studies in Pubmed that describe the phenotypic and functional heterogeneity of macrophages and the implications of targeting individual subsets, specifically in the context of mammary gland development and breast cancer. We also identified and summarized recent studies using single‐cell RNA sequencing to identify and describe macrophage subsets in human breast cancer samples.
Results
Advances in single‐cell RNA sequencing technologies have yielded nuances in macrophage heterogeneity, with numerous macrophage subsets identified in both the normal mammary gland and breast cancer tissue. Macrophage subsets contribute to mammary gland development and breast cancer progression in differing ways, and emerging studies highlight a role for spatial localization in modulating their phenotype and function.
Conclusion
Understanding macrophage heterogeneity and the unique functions of each subset in both normal mammary gland development and breast cancer progression may lead to more promising targets for the treatment of breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, Minnesota, USA.
- Molecular Pharmacology and Therapeutics Graduate Program, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
- Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
- Center for Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Kathryn L Schwertfeger
Förderung
- NCI NIH HHS
- NICHD NIH HHS
- National Cancer Institute
- National Institute of Child Health and Human Development
Zitieren
APA
Elfstrum, A. K., Bapat, A. S., & Schwertfeger, K. L. (2024). Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer. Cancer Medicine, 13(3). https://doi.org/10.1002/cam4.7053
Vancouver
Elfstrum AK, Bapat AS, Schwertfeger KL. Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer. Cancer Medicine. 2024;13(3). doi:10.1002/cam4.7053
BibTeX
@article{Elfstrum2024,
author = {Elfstrum, Alexis K and Bapat, Aditi S and Schwertfeger, Kathryn L},
title = {Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer},
journal = {Cancer Medicine},
year = {2024},
volume = {13},
number = {3},
doi = {10.1002/cam4.7053}
}
EUVIMED